Research to develop new techniques for studying wild and transgenic mice's nervous system

Researchers of the Pablo de Olavide University (Seville) have started different projects based on the study of phenotype techniques in mice and their applicability to the pharmaceutical industry and neurodegenerative medicine. It is a research conducted by the group 'División de Neurociencias', led by José María Delgado, that focuses on the development of new techniques for studying the behaviour and physiology of wild and transgenic mice's nervous system.

The goal of these projects, funded by the VIITh Framework Programme of the European Union, the Spanish Ministry of Research and Innovation, and the Spanish Andalusian Ministry of Innovation, Science and Enterprise, is to have a full range of electrophysiological and behavioural techniques, available for contracting by the specialized pharmaceutical industry in order to study pro-cognitive drugs or the effects on the motor and sensorial human system, as well as on learning and memory mechanisms, as a previous stage for its possible application in patients with different diseases (Alzheimer-like dementias, affectation of the motor human system, ataxias, etc.).

As Prof. Delgado explained to Andalucía Innova, 'the study of the behaviour and cognitive capacities in mammals whose biology is very close to humans will allow possible clinic applications in the short or medium term'. In that respect, this group of experts has scientific links to some companies such as French company Syntelabo - Aventis, the USA company Abbot, or Spanish companies Cibertec and Kytos, which has scientific and technological collaboration agreements in regenerative medicine and psychopharmacology. One of the developed products, specifically a pro-cognitive drug of Syntelabo - Aventis, is now in its phase 2, that is, about to be launched into the market.

In this line, these researchers mix with different national and foreign groups of their field of specialisation. So far there are 16 groups interested in this project and their animals are going to undergo trials too.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Research suggests no need for yellow fever vaccine booster after initial dose